<DOC>
	<DOCNO>NCT02659618</DOCNO>
	<brief_summary>The goal study identify serum biomarker ( ) detect increase level population CD15+ hypodense neutrophil term low-density granulocyte ( LDG ) blood patient severe persistent asthma .</brief_summary>
	<brief_title>Identification Serum Biomarkers CD15+ Hypodense Neutrophils Severe Asthma</brief_title>
	<detailed_description>Neutrophils implicated pathophysiology multiple asthma phenotype . It show study IST Q4935s low-density granulocyte ( LDG ) elevate blood patient moderate severe asthma . The great frequency high percentage LDG observe subject severe asthma . The LDG , first identify characterize systemic lupus erythematosus ( SLE ) patient , report display increase cytotoxicity endothelial cell , increase tendency form neutrophil extracellular trap , increase production tumor necrosis factor ( TNF ) . It also observe LDG express increased level CD15 , facilitate attachment activate platelet LDG . Identification putative serum biomarker correlate increase level CD15+ LDG may useful detection neutrophil-associated inflammation severe asthma . Thirty subject screen identify 20 subject severe persistent asthma . The following data and/or sample obtain within three week clinical assessment : ( 1 ) percentage LDG quantify flow cytometry ; ( 2 ) blood sample collect PAXgene Blood tube store ship Genentech gene profile analysis ; ( 3 ) serum sample collect measurement total immunoglobulin E ( IgE ) future confirmation potential biomarkers identify gene profile analysis .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Physician diagnosis severe persistent asthma ; Positive skin test radioallergosorbent test ( RAST ) aeroallergen ; Male female age 1265 year ; Nonsmoker . Asthma exacerbation require treatment increase oral corticosteroid within 30 day prior study ; Respiratory infection within 30 day prior study ; Starting require change allergen immunotherapy within 30 day prior study ; Having treat Xolair within past year ; Requiring chronic immunosuppressive therapy ; Having take methotrexate , gold salt , cyclosporine , macrolide antibiotic within 3 month prior study ; Having take investigational drug within 30 day prior study ; Have history drug alcohol abuse ; Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Asthma</keyword>
</DOC>